Crossmark

Associations between sarcopenic obesity and the risk of cardiovascular-kidney-metabolic syndrome progression: insights from the China health and retirement longitudinal study

Crossref DOI link: https://doi.org/10.1186/s13098-025-02032-9

Published Online: 2025-12-29

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Xin, Yijing

Qian, Xifeng

Yang, Yanmin
Funding

Funding for this research was provided by:

High level Hospital Clinical Research Funds (2022-GSP-GG-26)

High level Hospital Clinical Research Funds (2022-GSP-GG-26)

High level Hospital Clinical Research Funds (2022-GSP-GG-26)
License Information

Text and Data Mining valid from 2025-12-29

Version of Record valid from 2025-12-29
More Information

Article History

Received: 22 July 2025

Accepted: 15 November 2025

First Online: 29 December 2025

Declarations

:

: Peking University has obtained ethical approval for CHARLS (IRB00001052–11015). Clinical trial number: not applicable.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below